MT-ND3

Chr MT

NADH dehydrogenase subunit 3

Also known as: MTND3

This gene encodes a core subunit of NADH:ubiquinone oxidoreductase (Complex I) in the mitochondrial respiratory chain, which transfers electrons from NADH to ubiquinone during oxidative phosphorylation. Mutations cause Leigh syndrome and Complex I deficiency, with clinical severity depending on the degree of heteroplasmy. Inheritance follows a maternal pattern due to its location in the mitochondrial genome.

OMIMResearchSummary from Curated mito context
Multiplemechanism
Clinical SummaryMT-ND3
🧬
Gene-Disease Validity (ClinGen)
mitochondrial disease · MTDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Genetics & Constraint

Constraint data not available from gnomAD.

DN
0.86top 5%
GOF
0.72top 25%
LOF
0.11100th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

MT-ND3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →